Home / Health / Ozempic Shrinks Wall Street: Tailors See Wardrobe Revolution
Ozempic Shrinks Wall Street: Tailors See Wardrobe Revolution
31 Jan
Summary
- Tailors report significant client weight loss, requiring extensive wardrobe alterations.
- GLP-1 drug use for weight loss has surged, impacting garment industry.
- Wall Street's weight loss trend reshapes bespoke tailoring business models.

Wall Street professionals are undergoing significant transformations, with many investment bankers and executives returning to tailors with much slimmer frames. This shift, largely driven by the widespread use of GLP-1 drugs such as Ozempic, Wegovy, and Mounjaro, has led to a dramatic increase in suit alterations. Tailors like Michael Andrews in New York have seen clients bring back entire wardrobes, with dozens of garments requiring extensive adjustments due to substantial weight loss, sometimes reaching 20 to 30 pounds.
This trend, dubbed the 'Ozempic effect,' is reshaping the tailoring business. Andrews reported a more than tenfold increase in suit take-ins in 2025 compared to previous years, prompting him to expand his team. Other tailors echo this sentiment, noting a "dramatic impact" on their businesses. While alteration costs have risen, some see an upside as clients who achieve their desired weight often opt for entirely new wardrobes, reflecting a significant shift in consumer behavior and business demand.




